Mounjaro Tirzepatide Injection 7.5 Mg Box

Mounjaro Tirzepatide Injection 7.5 Mg Box

₹ 10,000 - ₹ 12,000 / Box

MOQ4 Box
Brand NameMounjaro Tirzepatide Injection
MaterialMounjaro Tirzepatide Injection
TypeBox
Supply TypeManufacturer, Exporter, Supplier, Retailer, Distributor, Importer, Trader, Buying House
Preferred Buyer Location All over the world

Mounjaro Tirzepatide Injection Mounjaro (Tirzepatide) Injection Product Description Eli Lilly and Company is proud to announce that the U.S. Food and Drug Administration (FDA) approved Mounjaro™....

Company Information

Member Since 2 Years
Nature of Business Exporter
GST No. 27AABPR4112P1ZH

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

Mounjaro Tirzepatide Injection

Mounjaro (Tirzepatide) Injection

Product Description

Eli Lilly and Company is proud to announce that the U.S. Food and Drug Administration (FDA) approved Mounjaro™ (tirzepatide) injection for the treatment of adults with type 2 diabetes as an adjunct to diet and exercise. The approval of Mounjaro represents the first new class of diabetes medication introduced in nearly a decade.Mounjaro is the first and only approved once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is a single molecule that targets the body's receptors for GIP and GLP-1, which are natural incretin hormones. Results from the global phase 3 SURPASS program supported this approval.